An interventional study of Extensively hydrolyzed casein formula (C-eHCF), commercially available and Extensively hydrolyzed casein formula (INV-eHCF) in Growth, sponsored by Mead Johnson Nutrition. Recruiting at 12 sites in United States. Open to participants aged 10 Days to 14 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Mead Johnson Nutrition (part of Reckitt) · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This is a research study to compare an investigational infant formula against a currently marketed infant formula. An investigational infant formula is one that has never been approved by the United States Food and Drug Administration (FDA).
The purpose of this research study is to evaluate the growth and tolerance of infants who consume a new (not yet available to buy) extensively hydrolyzed cow milk protein infant formula compared to an extensively hydrolyzed cow milk protein infant formula that is currently available to buy. The study will also look at the growth of your baby, how many poops your baby has, what the poops are like (for example, soft or hard), how much study formula your baby drinks, how well your baby handles the study formula (such as spit-up, fussiness, gas, colic, or changes in sleep), and any health problems that might come up during the study.
The current study is designed to demonstrate that an investigational extensively hydrolyzed casein formula developed utilizing a new manufacturing process, is well-accepted, tolerated and supports typical growth similar to a control extensively hydrolyzed casein formula in term, healthy infants from approximately 14 to 126 days of age. This formula has been determined to have a high-quality protein similar to that of intact casein, as seen in the protein efficiency ratio (PER) study. Secondary objectives will include tolerance, intake and stool characteristics between infants assigned to receive the control or the investigational formula through approximately 126 days of age. Control and investigational formulas have the same nutritional composition per 100 kcal.
Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.
First submitted after Mead Johnson Nutrition became part of Reckitt.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Other: Extensively hydrolyzed casein formula (C-eHCF), commercially available
Other: Extensively hydrolyzed casein formula (INV-eHCF)
A commercially available extensively hydrolyzed casein formula
An extensively hydrolyzed casein formula
Rate of weight gain (g/day)
Time frame: up to 131 days of age
body length (cm)
Time frame: up to 131 days of age
Head Circumference (cm)
Time frame: up to 131 days of age
Body weight (g)
Time frame: up to 131 days of age
Growth z-scores
head circumference-for-age
Time frame: up to 131 days of age
Growth Z Scores
weight-for-age
Time frame: up to 131 days of age
Growth Z Scores
Length-for-age
Time frame: up to 131 days of age
Stool characteristics
Time frame: up to 131 days of age
Study formula intake
Time frame: up to 131 days of age
Tolerance
Time frame: up to 131 days of age
Medically confirmed adverse events
Time frame: up to 131 days of age
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Aug 2027, 15 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 20, 2026: primary completion Dec 2026 → Aug 2027 and completion May 2027 → Nov 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.